Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
4 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Globant S.A.’s names, not what it holds today.
Patents granted
4
4 utility, 1976 to Dec 31, 2025
Granted in 2025
1
in the last year the record reads
Applications published
6
since 2001, to Dec 31, 2025
Names they are printed under
3
a subsidiary
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name3 counted
W2 Holdings, Inc. a subsidiary
US, as the owner printed on each patent
5 publishedLALIGA CONTENT PROTECTION, SL a subsidiary
ES, as the owner printed on each patent
0 publishedLALIGA CONTENT PROTECTION, SL a subsidiary
named as the applicant on its applications, in ES
1 publishedNames not counted (6)
Advanced Research & Technology S.A. de C.V.
Most of its patents print US; this name counts in MX. 6 granted and 1 published under it are not counted.
Globant S.A.
Most of its patents print US; this name counts in ES, LU. 1 granted and 1 published under it are not counted.
Vertic A/S
Most of its patents print FI; this name counts in DK. 2 granted and 0 published under it are not counted.
BSF S.A.
Most of its patents print DE; this name counts in AR. 0 granted and 1 published under it are not counted.
BSF S.A.
Most of its patents print DE; this name counts in AR. 0 granted and 1 published under it are not counted.
BSF S.A.
Most of its patents print DE; this name counts in AR. 0 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Feb 4, 2025 | 12,217,563 | Access control method and system | Control | LALIGA CONTENT PROTECTION, SL |
| Apr 9, 2013 | 8,415,107 | Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer | Analysis of biological materials | W2 Holdings, Inc. |
| Nov 8, 2011 | 8,053,196 | Clinical assays for thrombospondin fragments in the detection, diagnosis, and evaluation of cancer | Analysis of biological materials | W2 Holdings, Inc. |
| Feb 2, 2010 | 7,655,411 | Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer | Analysis of biological materials | W2 Holdings, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Oct 3, 2024 | 2024/0331475 | ACCESS CONTROL METHOD AND SYSTEM | Control | LALIGA CONTENT PROTECTION, SL · patent 12,217,563 granted from it |
| Feb 20, 2014 | 2014/0051098 | Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents | Analysis of biological materials | W2 Holdings, Inc. |
| Nov 1, 2012 | 2012/0276559 | Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents | Analysis of biological materials | W2 Holdings, Inc. |
| Oct 25, 2012 | 2012/0271124 | Thrombospondin Fragments and Uses Thereof In Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents | Analysis of biological materials | W2 Holdings, Inc. |
| Mar 17, 2011 | 2011/0065206 | Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents | Analysis of biological materials | W2 Holdings, Inc. |
| Jun 24, 2010 | 2010/0155245 | Thrombospondin Fragments and Binding Agents in the Detection, Diagnosis and Evaluation of Cancer | Analysis of biological materials | W2 Holdings, Inc. · patent 8,415,107 granted from it |
What it applied for, 2024 to 2025: Control 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.